📰 Registration Document News
Page 24 - Registration Document News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Document. Real-time updates on events, politics, business and more.
March 26, 2024
Regulated information: Filing of the 2023 Universal registration document Paris, March 26, 2024 Believe (Ticker: BLV, ISIN: FR0014003FE9), one of the...
March 26, 2024
Regulated information: Filing of the 2023 Universal registration document Paris, March 26, 2024 Believe , one of the leading digital music companies, announces today, Tuesday 26, 2024, that it...
March 25, 2024
Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 22, 2024, of its 2023 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing number D.24-0157 and its Form 20-F with the U.S. Securities and Exchange Commission (SEC). Valneva’s 2023 Universal Registration Document – available in its entirety in French – includes th...
March 25, 2024
FDA grants Orphan Drug Designation to ADV7103 for the treatment of cystinuria. • After distal Renal Tubular Acidosis in December 2022,...
March 25, 2024
Availability of the 2023 Universal Registration Document _PRESS RELEASE_ La Défense, March 25th, 2024 – The 2023 Universal Registration Document of Nexans has been filed with the AMF ...
March 25, 2024
Contacts Investor Relations: Arthur Carli - +33 1 47 17 24 65 - acarli@axway.com Press release Axways 2023 Universal...
March 25, 2024
Regulatory News: The French version of Axway’s 2023 Universal Registration Document in xHTML format, was filed today with the AMF , under number D.24-0175. The document is available on...
March 13, 2024
Regulatory News: Mercialys filed its 2023 Universal Registration Document with the French Financial Markets Authority on March 13, 2024, under number D.24-0104. The 2023 Universal Registration...
March 12, 2024
Not for publication, release, or distribution directly or indirectly in the United States, Canada, Australia or Japan.This press release is not an advertisement nor a prospectus within the meaning of...
March 11, 2024
Lyon and Cambridge , March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics , a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today...